CN107974466B - Sturgeon CRISPR/Cas9 gene editing method - Google Patents
Sturgeon CRISPR/Cas9 gene editing method Download PDFInfo
- Publication number
- CN107974466B CN107974466B CN201711282089.5A CN201711282089A CN107974466B CN 107974466 B CN107974466 B CN 107974466B CN 201711282089 A CN201711282089 A CN 201711282089A CN 107974466 B CN107974466 B CN 107974466B
- Authority
- CN
- China
- Prior art keywords
- sturgeon
- acipenser
- cas9
- gene
- grna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000881711 Acipenser sturio Species 0.000 title claims abstract description 38
- 108091033409 CRISPR Proteins 0.000 title claims abstract description 34
- 238000000034 method Methods 0.000 title claims abstract description 28
- 238000010362 genome editing Methods 0.000 title claims abstract description 17
- 238000010354 CRISPR gene editing Methods 0.000 title claims abstract description 11
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 37
- 241000252335 Acipenser Species 0.000 claims abstract description 34
- 108020005004 Guide RNA Proteins 0.000 claims abstract description 23
- 235000013601 eggs Nutrition 0.000 claims abstract description 17
- 241001465754 Metazoa Species 0.000 claims abstract description 11
- 230000004720 fertilization Effects 0.000 claims abstract description 10
- 238000000520 microinjection Methods 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 241000251468 Actinopterygii Species 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 7
- 241001125075 Acipenser baerii Species 0.000 claims description 5
- 241000162143 Acipenser schrenckii Species 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 239000000872 buffer Substances 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 239000011521 glass Substances 0.000 claims description 3
- 241000252344 Acipenser gueldenstaedtii Species 0.000 claims description 2
- 230000037396 body weight Effects 0.000 claims description 2
- 101150038500 cas9 gene Proteins 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 230000009027 insemination Effects 0.000 claims description 2
- 230000016087 ovulation Effects 0.000 claims description 2
- 230000001568 sexual effect Effects 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims 1
- 230000006698 induction Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 238000005516 engineering process Methods 0.000 abstract description 15
- 210000002257 embryonic structure Anatomy 0.000 abstract description 11
- 238000009395 breeding Methods 0.000 abstract description 9
- 230000001488 breeding effect Effects 0.000 abstract description 9
- 230000035772 mutation Effects 0.000 abstract description 8
- 210000001161 mammalian embryo Anatomy 0.000 abstract description 4
- 238000012216 screening Methods 0.000 abstract description 3
- 230000012447 hatching Effects 0.000 abstract description 2
- 102000007999 Nuclear Proteins Human genes 0.000 abstract 1
- 108010089610 Nuclear Proteins Proteins 0.000 abstract 1
- 235000019688 fish Nutrition 0.000 description 8
- 230000002068 genetic effect Effects 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 241000252355 Acipenser ruthenus Species 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 206010064571 Gene mutation Diseases 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 108010017070 Zinc Finger Nucleases Proteins 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000012214 genetic breeding Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000036438 mutation frequency Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 241000883303 Acipenser sinensis Species 0.000 description 1
- 108700031361 Brachyury Proteins 0.000 description 1
- 241000721179 Clarias Species 0.000 description 1
- 241000252203 Clupea harengus Species 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 241000594011 Leuciscus leuciscus Species 0.000 description 1
- 241001327682 Oncorhynchus mykiss irideus Species 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 241000276707 Tilapia Species 0.000 description 1
- 101150063416 add gene Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/05—Animals modified by non-integrating nucleic acids, e.g. antisense, RNAi, morpholino, episomal vector, for non-therapeutic purpose
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/40—Fish
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Environmental Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention provides a sturgeon CRISPR/Cas9 gene editing method, which is characterized in that Cas9 protein and target gene gRNA are mixed and injected into a sperm receiving hole of an animal pole of sturgeon 1 cell fertilized eggs with fertilization time not more than 20 minutes by a microinjection method. Mixing 100 ng/muL Cas9 nuclear protein and 30 ng/muL gRNA, introducing the mixture into an animal pole of a sperm-bearing embryo in a cell stage of acipenser ruthenicus 1 by adopting a microinjection method, and obtaining the acipenser ruthenicus embryo with the mutation rate of a target gene as high as 83.1% after hatching, thereby establishing an acipenser ruthenicus target gene accurate editing technology. The acipenser parvus embryos with mutated target genes can be obtained by screening through a PAGE method. The technology can be used for researching the functions of sturgeon genes, can also be used for accurately modifying sturgeon endogenous target genes, and can be used for breeding genetically improved sturgeon breeding new strains.
Description
Technical Field
The invention relates to the technical field of aquatic animal genetic breeding and functional gene verification research, in particular to a sturgeon CRISPR/Cas9 gene editing method.
Background
Sturgeon is in the transition period between cartilaginous fish and bony fish in the aspect of biological system evolution, has a multiplicized genome, and has important research value in the aspects of researching fish gene function and evolution. However, studies on gene function in sturgeons have been performed, and the conventional reports are limited to gene cloning and expression pattern analysis (Abdolahnejad et al, 2015.Dong et al, 2015.Fajkowska et al, 2016.Song et al, 2016.Yarmohammadi et al, 2017). Sturgeon fish belongs to large economic fish. Sturgeons are not only delicious in meat quality and comprehensive in nutrition and rich in various essential amino acids and unsaturated fatty acids for human bodies, but also are important caviar production materials (Simeanu et al, 2012). However, wild sturgeon resources have been rapidly declining due to human over-fishing and destruction of aquatic ecosystems, and many sturgeons are even in endangered states (Billard et al, 2000).
Developing the genetic breeding of sturgeons and cultivating sturgeon breeding varieties are key points for meeting the increasing demands of human beings on sturgeon products and protecting wild sturgeon resources. However, sturgeon gene function research and genetic improvement breeding are always limited by the lack of effective technical means.
The gene editing technology is a technology for carrying out site-directed mutation or accurate modification on a genome by utilizing a targeted sequence-specific nuclease, and comprises a Zinc Finger Nuclease (ZFN), a TALE nuclease and a CRISPR/Cas9 system. Gene editing techniques have found wide application in gene function studies and genetic improvement of economic species. Efficient gene editing techniques have been established so far in model fish such as zebrafish, herring and economic fish such as tilapia, rainbow trout, carp, clarias canaliculata, dace semilaevis and finless eel (Doyon et al, 2008; Ansai et al, 2013; Qiu et al, 2014; Li et al, 2014; Yano et al, 2014; Zhong et al, 2016; Qin et al, 2016; Chakrapani et al, 2016; Cui et al, 2017; Feng et al, 2017). However, no gene editing technology has been established in sturgeons to date.
Therefore, the sturgeon gene editing technology is established, and on one hand, the sturgeon gene editing technology can be used for sturgeon functional gene research; on the other hand, the method can be used for exploring and developing a new sturgeon breeding strain, providing a good genetic improvement variety for breeding sturgeons, and protecting sturgeon wild resources.
Disclosure of Invention
The invention provides a sturgeon CRISPR/Cas9 gene editing method, which comprises the steps of constructing a regular Clustered spaced short palindromic repeats (Clustered regular intercalary short palindromic repeats 9, CRISPRs/Cas9) gene editing vector of a target gene, transcribing the gRNA of the target gene in vitro, mixing Cas9 nucleolase protein with the gRNA of the target gene, introducing the mixture into animal polar sperm-receiving pores of fertilized eggs of sturgeon in a 1-cell period, wherein the fertilization time of the animal polar sperm-receiving pores is not more than 20 minutes, and hatching to obtain the sturgeon with the target gene mutation.
In order to achieve the purpose, the invention adopts the following technical measures:
a method of sturgeon CRISPR/Cas9 gene editing comprising: cas9 protein and target gene gRNA are mixed and then injected into a sperm receiving hole of an animal pole of a sturgeon fertilized egg at the 1 cell stage with the fertilization time not exceeding 20 minutes by a microinjection mode;
in the above method, preferably, the sturgeons include, but are not limited to, acipenser baeri (a. bairii), acipenser schrenckii (a. schrenckii), and acipenser russiamensis (a. gueldenstatii);
in the above-described method, preferably, the final concentrations of the Cas9 protein and the target gene gRNA are 100 ng/. mu.l and 30 ng/. mu.l, respectively;
in the above-described method, preferably, the injection volume per fertilized egg is 2 nL.
Compared with the prior art, the invention has the following advantages:
at present, no micromanipulation technology for sturgeon embryos exists, and no technology for accurately editing endogenous genes of sturgeons exists. The invention establishes a sturgeon endogenous gene precise editing technology for the first time, and provides a powerful technical means for developing sturgeon gene function research and sturgeon breeding breed genetic improvement.
The existing system for editing genes, which is a Clustered regularly interspaced short palindromic repeats (CRISPRs/Cas 9), usually adopts a mode of co-injecting Cas9mRNA and guide RNA (gRNA). Since Cas9mRNA is translated into protein and then functions after entering into cells, the intracellular translation efficiency of Cas9mRNA affects the mutation efficiency of endonuclease. The invention adopts a mode of directly injecting the Cas9 protein, omits the process of mRNA translation, and improves the cutting frequency of the Cas9 endonuclease to the target site. Only a gRNA vector of a target gene such as ntl needs to be constructed and transcribed in vitro to synthesize a gRNA. Cas9 protein and gRNA aiming at a gene target site are mixed according to the concentration (final concentration) of 100 ng/mu L and 30 ng/mu L, and are introduced into fertilized eggs of the Acipenser parvum 1 at the cell stage by adopting a microinjection method, the survival rate is 93.9 percent, and the Acipenser parvum embryo with the target gene mutation rate up to 83.1 percent can be obtained, so that the Acipenser parvum target gene precise editing technology is established. The acipenser parvus embryos with mutated target genes can be obtained by screening through a PAGE method. The technology can be used for researching the functions of sturgeon genes, can also be used for accurately modifying sturgeon endogenous target genes, and can be used for breeding genetically improved sturgeon breeding new strains.
Drawings
FIG. 1 shows the partial sequence of the first exon and the gRNA target site of the Acipenser aethiopica ntl gene;
underlined sequences are targets and black triangles indicate the position where Cas9 enzyme cleaves the DNA double strand.
FIG. 2 is an animal pole fertilization hole of fertilized egg of Acipenser parvum 1 at cell stage;
arrows indicate animal polar seminiferous wells.
FIG. 3 is a schematic diagram of the detection of Acipenser parvum ntl gene mutation;
in fig. 3 a: detecting the mutation rate of the target sites of 7 injected embryos; the Hm corresponding band represents the DNA fragment of the target site without mutation, and the Ht corresponding band represents the DNA fragment of the target site with reduced, increased or changed base;
b in FIG. 3: calculating the mutation frequency of the target site according to the Ht band and the Hm band brightness;
c in FIG. 3: the 3 rd and 4 th embryos are tested, and the spine is seen to be bent and the tail is seen to be shortened.
The specific implementation mode is as follows:
the technical solutions of the present invention, if not specifically mentioned, are conventional in the art, and the reagents or materials, if not specifically mentioned, are commercially available. The invention takes the editing of the gene ntl of the acipenser ruthenus as an example, establishes a precise gene editing technology of the endogenous gene of the acipenser ruthenus, and the technology can be used for researching the function of the gene of the acipenser ruthenus and the genetic improvement of the variety of the acipenser ruthenus.
Example 1:
a method for sturgeon CRISPR/Cas9 gene editing, comprising the following steps:
1) obtaining fertilized eggs of Acipenser parvum 1 in a cell stage:
selecting sexual mature acipenser parvum parent fish, and temporarily culturing in an indoor culture system. 36 from artificial reproductionBefore an hour, injecting a mixture of LHR Ha and DOM for artificial induced spawning, wherein the injection dose is 10 mu g LHRHA +1mg DOM/kg body weight, injecting the mixture for 1 time every 12 hours, continuously injecting female sturgeons for 2 times, and injecting male sturgeons for 1 time, extruding semen to a dry beaker when the parent fish has the symptom of semen discharge/ovulation, extruding eggs to a glass plate, and injecting 0.3 × Danieau buffer [17mM NaCl, 2M KCl, 0.12mM MgSO ]4,1.8mM Ca(NO3)2,1.5mM HEPES,pH 7.6]The semen is diluted 100 times for artificial insemination. Fertilization time is 1 minute, and then redundant semen is washed out, so that fertilized eggs of the Acipenser parvum which can be used for microinjection are obtained.
2) Construction of guide RNA for Acipenser parvum target Gene (ntl):
aiming at a target gene ntl (Genebank MG520324) of Acipenser parvifilis, a gRNA target point is designed by using a design website (http:// ZiFiT. paratners. org/ZiFiT /), and is GGCTTGAAGACGTGGATCTT (figure 1). Guide RNA (gRNA) was synthesized according to the methods described in the literature [ Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh JR, journal JK (2013) Efficient genome editing in zebraffing use a CRISPR-Cas system. Nat Biotechnol 31: 227-. The method comprises the following specific steps: two Oligo sequences were synthesized, F1-TAG GCTTGAAGACGTGGATCTT, R1-AAACAAGATCCACGTCTTCAAG. The F1 and R1 primers were mixed at 10mM each, and were first incubated at 95 ℃ for 5 minutes and then slowly cooled to 37 ℃. The DR274 plasmid (Addgene plasmid 42250) was digested with BsaI (NEB, R0535) and ligated to the annealed product. The ligation product was transformed into competent E.coli. PCR was performed using primer M13(-47) and primer F1 to pick out positive clones. The PCR reaction conditions are as follows: 95 ℃ for 2 minutes, 95 ℃ for 15 seconds, 56 ℃ for 15 seconds, 72 ℃ for 30 seconds (30 cycles), 72 ℃ for 5 minutes. Plasmids were extracted by conventional methods. After digestion with DraI (NEB, R0129), a fragment of about 200bp was recovered from the gel, transcribed into gRNA in vitro using MEGAshortscript kit (Ambion, AM1354), and purified. Cas9 protein was purchased from Life Technologies (B25640). Cas9 protein was mixed with gRNAs and a small amount of RNase-free phenol red was added to a final concentration of Cas 9100 ng/. mu.L and gRNAs 30 ng/. mu.L.
3) Fertilized egg of Acipenser parvum in 1 cell stage by microinjection
Placing the fertilized eggs of the Acipenser parvum 1 with the fertilization time not more than 20 minutes prepared in the step 1) in a glass culture dish slightly covered with 0.3 x Da nieau buffer. Acipenser sinensis embryonic animals were adjusted polar up under a stereomicroscope (Olympus, Japan). The mixed solution of Cas9 protein and gRNA was injected into the fertilization well of the fertilized egg animal pole of acipenser baeri 1 cell stage one by one using a nitrogen pressurized quantitative microinjection system (Warner PLI-100A, usa) with an injection volume of 2nL per fertilized egg. The microinjected embryos were cultured at 16 ℃ with a survival rate of 93.9%.
4) Screening of Acipenser parvum embryos with ntl mutated target genes
8 days after fertilization, the microinjected embryos developed to the time of emergence, the embryos were collected individually and genomic DNA was extracted by conventional methods. The gene portion fragment containing the target site was amplified with the detection primers F2-GGAGAGCGAATTTCAGAA and R2-GCGCAATGTCATTT TAATAC. The PCR reaction conditions are as follows: 95 ℃ for 1 min, 95 ℃ for 15 sec, 52 ℃ for 15 sec, 72 ℃ for 30 sec (30 cycles), 72 ℃ for 5 min. Finally, the PCR product was left at 95 ℃ for 1 minute and then slowly cooled to 37 ℃. The final PCR product was electrophoresed on 8% polyacrylamide gel (PAGE) at 80V for 1.5 hours, and the gel was stained with EB. The frequency of mutation at the target site was calculated according to the number of electrophoretic bands and brightness by the method described in the literature [ Chen J, Zhang X, Wang T, Li Z, Guan G, Hong Y (2012) effectiveness detection, qu identification and evaluation of sublle allometric methods. DNASES 19:423-433 ]. According to the detection result, mutation of the target site was detected in 7 microinjected embryos, the highest mutation rate reached 83.1% (fig. 3), and meanwhile, two embryos with higher mutation frequency showed a bent spine and shortened tail phenotype, which is similar to the phenotype of the knocked-down zebrafish ntl gene.
Example 2:
ntl genes of different sturgeons were selected as target genes, target gRNAs were constructed in a conventional manner in the art, and embryo micromanipulation was successfully performed in Siberian sturgeons (A. bairi), Schrenckii, and Russian sturgeons (A. gueldenstii) according to the method in example 1.
Claims (4)
1. A method of sturgeon CRISPR/Cas9 gene editing comprising: cas9 protein and target gene gRNA are mixed and then injected into a sperm receiving hole of an animal pole of a sturgeon fertilized egg at the 1 cell stage with the fertilization time not exceeding 20 minutes by a microinjection mode;
the preparation method of the fertilized egg comprises the following steps: selecting sexual mature sturgeon parent fish, and temporarily culturing in an indoor culture system; injecting a mixture of LHRHA and DOM 36 hours before artificial propagation for artificial spawning induction, wherein the injection dose is 10 mug LHRHA +1mg DOM/kg body weight, injecting the mixture for 1 time every 12 hours, continuously injecting female sturgeons for 2 times, and injecting male sturgeons for 1 time; extruding semen into a dry beaker when the parent fish has the sign of spermiation/ovulation, and extruding eggs into a glass plate; diluting the semen by 100 times by 0.3 times Daniea u buffer for artificial insemination; fertilization time is 1 minute, and then redundant semen is washed away, so that sturgeon fertilized eggs which can be used for microinjection are obtained;
the Danieau buffer is as follows: 17mM NaCl, 2mM KCl, 0.12mM MgSO4,1.8mM Ca(NO3)2,1.5mMHEPES,pH 7.6。
2. A method according to claim 1, wherein the sturgeon comprises acipenser baeri, acipenser baeri (a. baieri), acipenser schrenckii (a. schrenckii), or acipenser russian (a. gueldenstaedii).
3. The method of claim 1, wherein the final concentration of the Cas9 protein and the gRNA of the target gene are 100ng/μ L and 30ng/μ L respectively.
4. The method of claim 1, wherein each zygote is injected in a volume of 2 nL.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711282089.5A CN107974466B (en) | 2017-12-07 | 2017-12-07 | Sturgeon CRISPR/Cas9 gene editing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711282089.5A CN107974466B (en) | 2017-12-07 | 2017-12-07 | Sturgeon CRISPR/Cas9 gene editing method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107974466A CN107974466A (en) | 2018-05-01 |
CN107974466B true CN107974466B (en) | 2020-09-29 |
Family
ID=62009532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711282089.5A Active CN107974466B (en) | 2017-12-07 | 2017-12-07 | Sturgeon CRISPR/Cas9 gene editing method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107974466B (en) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10323236B2 (en) | 2011-07-22 | 2019-06-18 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
US20150044192A1 (en) | 2013-08-09 | 2015-02-12 | President And Fellows Of Harvard College | Methods for identifying a target site of a cas9 nuclease |
US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
US9388430B2 (en) | 2013-09-06 | 2016-07-12 | President And Fellows Of Harvard College | Cas9-recombinase fusion proteins and uses thereof |
US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
US9840699B2 (en) | 2013-12-12 | 2017-12-12 | President And Fellows Of Harvard College | Methods for nucleic acid editing |
EP3177718B1 (en) | 2014-07-30 | 2022-03-16 | President and Fellows of Harvard College | Cas9 proteins including ligand-dependent inteins |
EP3365356B1 (en) | 2015-10-23 | 2023-06-28 | President and Fellows of Harvard College | Nucleobase editors and uses thereof |
GB2568182A (en) | 2016-08-03 | 2019-05-08 | Harvard College | Adenosine nucleobase editors and uses thereof |
AU2017308889B2 (en) | 2016-08-09 | 2023-11-09 | President And Fellows Of Harvard College | Programmable Cas9-recombinase fusion proteins and uses thereof |
US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
KR102622411B1 (en) | 2016-10-14 | 2024-01-10 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | AAV delivery of nucleobase editor |
WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
US11898179B2 (en) | 2017-03-09 | 2024-02-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
WO2018165629A1 (en) | 2017-03-10 | 2018-09-13 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
EP3601562A1 (en) | 2017-03-23 | 2020-02-05 | President and Fellows of Harvard College | Nucleobase editors comprising nucleic acid programmable dna binding proteins |
WO2018209320A1 (en) | 2017-05-12 | 2018-11-15 | President And Fellows Of Harvard College | Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation |
US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
EP3676376A2 (en) | 2017-08-30 | 2020-07-08 | President and Fellows of Harvard College | High efficiency base editors comprising gam |
KR20200121782A (en) | 2017-10-16 | 2020-10-26 | 더 브로드 인스티튜트, 인코퍼레이티드 | Uses of adenosine base editor |
CN109385451B (en) * | 2018-11-07 | 2020-07-07 | 中国海洋大学 | Oyster CRISPR/Cas9 gene editing method |
BR112021018606A2 (en) | 2019-03-19 | 2021-11-23 | Harvard College | Methods and compositions for editing nucleotide sequences |
DE112021002672T5 (en) | 2020-05-08 | 2023-04-13 | President And Fellows Of Harvard College | METHODS AND COMPOSITIONS FOR EDIT BOTH STRANDS SIMULTANEOUSLY OF A DOUBLE STRANDED NUCLEOTIDE TARGET SEQUENCE |
CN111549030A (en) * | 2020-05-26 | 2020-08-18 | 上海海洋大学 | Molecular breeding method for thickening crucian muscles |
CN111549031A (en) * | 2020-05-26 | 2020-08-18 | 上海海洋大学 | Molecular breeding method for thickening muscle of grass carp and black carp |
CN111500581A (en) * | 2020-05-26 | 2020-08-07 | 上海海洋大学 | Molecular breeding method for thickening muscle between silver carps and bighead carps |
CN111560401A (en) * | 2020-05-26 | 2020-08-21 | 上海海洋大学 | Molecular breeding method for thickening interpuscular spurs of erythroculter ilishaeformis and megalobrama amblycephala |
CN112779258A (en) * | 2021-03-02 | 2021-05-11 | 福建农林大学 | Large yellow croaker CRISPR/Cas9 gene editing method |
CN113862304B (en) * | 2021-09-09 | 2023-08-22 | 中国科学院海洋研究所 | CRISPR/Cas9 gene editing method for haliotis discus |
CN114214364B (en) * | 2021-12-01 | 2022-10-25 | 中国科学院海洋研究所 | Method for constructing stichopus japonicus gene editing system |
CN114231561A (en) * | 2021-12-22 | 2022-03-25 | 重庆医科大学 | Method for knocking down animal mRNA based on CRISPR-Cas13d and application thereof |
CN114438132A (en) * | 2022-02-16 | 2022-05-06 | 西南大学 | Establishment method of nile tilapia mstnb homozygous knockout line and fast-growing strain obtained by same |
CN114634951B (en) * | 2022-05-11 | 2022-08-16 | 中山大学 | Siniperca chuatsi CRISPR/Cas9 gene editing method and application thereof |
CN114686524B (en) * | 2022-06-01 | 2022-09-30 | 中山大学 | Method for producing 1-year-old female yellow-fin sparus by gene editing |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014070887A1 (en) * | 2012-10-30 | 2014-05-08 | Recombinetics, Inc. | Control of sexual maturation in animals |
CN104195177A (en) * | 2014-08-05 | 2014-12-10 | 南京大学 | Method for remarkably improving fish genome editing efficiency |
CN106222204A (en) * | 2016-08-10 | 2016-12-14 | 中国科学院水生生物研究所 | A kind of method of Monopterus albus (Zuiew) gene editing |
-
2017
- 2017-12-07 CN CN201711282089.5A patent/CN107974466B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014070887A1 (en) * | 2012-10-30 | 2014-05-08 | Recombinetics, Inc. | Control of sexual maturation in animals |
CN104195177A (en) * | 2014-08-05 | 2014-12-10 | 南京大学 | Method for remarkably improving fish genome editing efficiency |
CN106222204A (en) * | 2016-08-10 | 2016-12-14 | 中国科学院水生生物研究所 | A kind of method of Monopterus albus (Zuiew) gene editing |
Also Published As
Publication number | Publication date |
---|---|
CN107974466A (en) | 2018-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107974466B (en) | Sturgeon CRISPR/Cas9 gene editing method | |
US20220015342A1 (en) | Gene editing of reproductive hormones to reduce fertility in ictalurus punctatus | |
CN105861554B (en) | method for realizing animal sex control based on editing Rbmy gene and application | |
Dong et al. | Heritable targeted inactivation of myostatin gene in yellow catfish (Pelteobagrus fulvidraco) using engineered zinc finger nucleases | |
Liu et al. | Targeted disruption of tyrosinase causes melanin reduction in Carassius auratus cuvieri and its hybrid progeny | |
Lu et al. | Production of transgenic silver sea bream (Sparus sarba) by different gene transfer methods | |
CN106191114A (en) | CRISPR Cas9 system is utilized to knock out the breeding method of Fish MC4R gene | |
Fujimura et al. | Tol2-mediated transgenesis in tilapia (Oreochromis niloticus) | |
Sin et al. | Gene transfer in chinook salmon (Oncorhynchus tshawytscha) by electroporating sperm in the presence of pRSV-lacZ DNA | |
US8258369B2 (en) | Method for preparing fish embryos | |
CN108103108A (en) | The preparation and its application of Cebpa gene delection zebra fish mutant | |
Astre et al. | The African turquoise killifish (Nothobranchius furzeri): biology and research applications | |
CN113736787A (en) | gRNA of targeted mouse Atp7b gene and method for constructing Wilson disease mouse model | |
Li et al. | Establishment, characterization, and transfection potential of a new continuous fish cell line (CAM) derived from the muscle tissue of grass goldfish (Carassius auratus) | |
CN105505879A (en) | Method and culture medium for culturing transgenic animal embryonic cells or transgenic animals | |
CN112226465B (en) | Application of isolated nucleotide sequence in construction of mineralizeless intermuscular bone zebra fish | |
CN107760722B (en) | Method for microinjection of sturgeons and application | |
Ou et al. | Generation of myostatin gene-edited blotched snakehead (Channa maculata) using CRISPR/Cas9 system | |
Ishibashi et al. | A method for generating transgenic frog embryos | |
KR20170133380A (en) | How to produce non-human large mammals or fish producing spouses from this individual | |
CN115720874A (en) | Creating method and application of inonotus spiny germplasm for cultured economic fishes | |
CN108034675B (en) | Sturgeon TALEN gene editing method | |
Xu et al. | Rapid establishment of Oct4: EGFP transgenic zebrafish homozygote through gynogenesis for monitoring the pluripotency during induction of pluripotent stem cells | |
CN115627275A (en) | Mandarin rice CRISPR/Cas9n gene editing method | |
CN103923215B (en) | Make material and the application thereof of ACC-α gene promoter P III inactivation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |